Trial intelligence / Profile preview

Deep Neuromuscular Blockade and Low Pressure in Laparoscopic Hysterectomy

NCT01722097Phase 4Completed

Sponsor
Herlev Hospital
Start
Nov 2012
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of rocuronium in laparoscopic hysterectomy (2 arms), sponsored by Herlev Hospital. Primary endpoint: Shoulder Pain at 14 days. Started Nov 2012; status: completed.

02

Drugs

rocuronium
03

Conditions

laparoscopic hysterectomy

Beyond the preview

Go deeper on NCT01722097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01722097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call